Boxer Capital as of March 31, 2017
Portfolio Holdings for Boxer Capital
Boxer Capital holds 31 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Avexis | 17.1 | $78M | 1.0M | 76.03 | |
Clovis Oncology | 13.9 | $64M | 1.0M | 63.67 | |
Medicines Company | 13.0 | $59M | 1.2M | 48.90 | |
Esperion Therapeutics (ESPR) | 9.8 | $45M | 1.3M | 35.31 | |
Medicines | 7.3 | $33M | 684k | 48.90 | |
Beigene (BGNE) | 6.8 | $31M | 850k | 36.61 | |
Blueprint Medicines (BPMC) | 6.7 | $31M | 770k | 39.99 | |
Ptc Therapeutics I (PTCT) | 3.2 | $15M | 1.5M | 9.84 | |
Aquinox Pharmaceuticals | 3.2 | $15M | 878k | 16.69 | |
Incyte Corporation (INCY) | 2.9 | $13M | 100k | 133.67 | |
Alnylam Pharmaceuticals (ALNY) | 2.8 | $13M | 250k | 51.25 | |
Alexion Pharmaceuticals | 2.0 | $9.1M | 75k | 121.24 | |
Seattle Genetics | 1.4 | $6.3M | 100k | 62.86 | |
Mirati Therapeutics | 1.2 | $5.4M | 1.0M | 5.20 | |
La Jolla Pharmaceuticl Com Par | 1.1 | $5.0M | 167k | 29.85 | |
Kura Oncology (KURA) | 1.0 | $4.7M | 533k | 8.80 | |
Strongbridge Bioph shs usd | 1.0 | $4.5M | 940k | 4.75 | |
Puma Biotechnology (PBYI) | 0.8 | $3.7M | 100k | 37.20 | |
Cymabay Therapeutics | 0.7 | $3.3M | 777k | 4.30 | |
Syndax Pharmaceuticals (SNDX) | 0.7 | $3.2M | 234k | 13.72 | |
Bellerophon Therapeutics | 0.6 | $2.8M | 1.9M | 1.49 | |
Sunesis Pharmaceuticals Inc Ne | 0.5 | $2.2M | 525k | 4.10 | |
Nabriva Therapeutics | 0.5 | $2.1M | 177k | 12.00 | |
Eiger Biopharmaceuticals | 0.3 | $1.6M | 138k | 11.45 | |
Aldeyra Therapeutics (ALDX) | 0.3 | $1.5M | 291k | 5.00 | |
Anaptysbio Inc Common (ANAB) | 0.3 | $1.4M | 50k | 27.76 | |
Akari Therapeutics | 0.2 | $1.1M | 95k | 11.07 | |
Onconova Therapeutics | 0.2 | $962k | 316k | 3.04 | |
Aradigm | 0.2 | $893k | 576k | 1.55 | |
Nexvet Biopharma Pub Ltd Co ord | 0.1 | $602k | 155k | 3.89 | |
Onconova Therapeutics Inc *w exp 07/07/202 | 0.0 | $203k | 242k | 0.84 |